Compare LIC MF Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹200 | ₹500 |
Expense Ratio | 2.45 | 1.93 |
NAV | ₹28.73 | ₹416.25 |
Fund Started | 08 Feb 2019 | 04 Jun 1999 |
Fund Size | ₹83.12 Cr | ₹3989.42 Cr |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹200
₹500
Expense Ratio
2.45
1.93
NAV
₹28.73
₹416.25
Fund Started
08 Feb 2019
04 Jun 1999
Fund Size
₹83.12 Cr
₹3989.42 Cr
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Exit load of 0.50% if redeemed within 15 days
1 Year | -0.74% | 0.20% |
3 Year | 19.68% | 23.54% |
5 Year | 11.20% | 15.54% |
1 Year
-0.74%
0.20%
3 Year
19.68%
23.54%
5 Year
11.20%
15.54%
Equity | 98.02% | 96.59% |
Cash | 1.98% | 3.34% |
Equity
98.02%
96.59%
Cash
1.98%
3.34%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.85% |
Torrent Pharmaceuticals Ltd. | 6.08% |
Apollo Hospitals Enterprise Ltd. | 5.70% |
Cipla Ltd. | 5.68% |
Divi's Laboratories Ltd. | 4.74% |
Neuland Laboratories Ltd. | 4.51% |
Fortis Healthcare Ltd. | 4.48% |
Aurobindo Pharma Ltd. | 4.46% |
Piramal Pharma Ltd. | 4.32% |
Onesource Specialty Pharma Ltd. | 3.88% |
Sun Pharmaceutical Industries Ltd. | 11.64% |
Divi's Laboratories Ltd. | 7.05% |
Max Healthcare Institute Ltd. | 5.24% |
Lupin Ltd. | 4.44% |
Laurus Labs Ltd. | 3.89% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Acutaas Chemicals Ltd. | 3.85% |
Cipla Ltd. | 3.79% |
Lonza Group Ag | 3.63% |
Biocon Ltd. | 3.16% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 08 Feb 2019 | 04 Jun 1999 |
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
08 Feb 2019
04 Jun 1999